Supplemental material
Expert Review of Vaccines
Volume 22, 2023 - Issue 1
Original Research
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance
Diana Mendesa Health & Value, Evidence Synthesis, Modeling and Communication, Pfizer Ltd, Tadworth, UK
https://orcid.org/0000-0002-1672-4906View further author information
https://orcid.org/0000-0002-1672-4906View further author information, , , , , , Manuela Di Fuscof Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USAhttps://orcid.org/0000-0003-0079-7331View further author information
https://orcid.org/0000-0003-0079-7331View further author information, & Jingyan Yangf Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA;h Institute for Social and Economic Research and Policy, Graduate School of Arts and Science, Columbia University, New York, NY, USACorrespondence[email protected]
https://orcid.org/0000-0001-5523-649XView further author information
https://orcid.org/0000-0001-5523-649XView further author information show all